The physiotherapy instrument market encompasses devices used to assess, monitor, and treat musculoskeletal, neurological, and cardiopulmonary conditions through electrotherapy, ultrasound, laser, thermotherapy, and mechanical traction. With global healthcare shifting toward non-pharmacological pain management and accelerated rehabilitation, these instruments have become pivotal in reducing re-admissions, shortening hospital stays, and improving quality of life for aging and chronic-disease populations. The physiotherapy instrument market size is projected to reach USD 8.5 billion in 2025 (base year) and grow at a CAGR of ~6.8% to USD 14.3 billion by 2033, reflecting a robust growth outlook underpinned by the rising incidence of sports injuries, post-COVID-19 rehabilitation needs, and expanding reimbursement for outpatient physiotherapy services in North America, Europe, and parts of Asia-Pacific.